» Articles » PMID: 26937922

Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies

Overview
Specialty General Medicine
Date 2016 Mar 4
PMID 26937922
Citations 194
Authors
Affiliations
Soon will be listed here.
Abstract

Child-Pugh and MELD scores have been widely used for the assessment of prognosis in liver cirrhosis. A systematic review and meta-analysis aimed to compare the discriminative ability of Child-Pugh versus MELD score to assess the prognosis of cirrhotic patients.PubMed and EMBASE databases were searched. The statistical results were summarized from every individual study. The summary areas under receiver operating characteristic curves, sensitivities, specificities, positive and negative likelihood ratios, and diagnostic odds ratios were also calculated.Of the 1095 papers initially identified, 119 were eligible for the systematic review. Study population was heterogeneous among studies. They included 269 comparisons, of which 44 favored MELD score, 16 favored Child-Pugh score, 99 did not find any significant difference between them, and 110 did not report the statistical significance. Forty-two papers were further included in the meta-analysis. In patients with acute-on-chronic liver failure, Child-Pugh score had a higher sensitivity and a lower specificity than MELD score. In patients admitted to ICU, MELD score had a smaller negative likelihood ratio and a higher sensitivity than Child-Pugh score. In patients undergoing surgery, Child-Pugh score had a higher specificity than MELD score. In other subgroup analyses, Child-Pugh and MELD scores had statistically similar discriminative abilities or could not be compared due to the presence of significant diagnostic threshold effects.Although Child-Pugh and MELD scores had similar prognostic values in most of cases, their benefits might be heterogeneous in some specific conditions. The indications for Child-Pugh and MELD scores should be further identified.

Citing Articles

Assessment of non-tumor liver parenchyma damage in advanced gastric cancer treatment with transarterial infusion chemotherapy: a study using imaging and hepatic injury indicators.

Jing Y, Jing J, Sun X, Jin Y, Bai X Front Oncol. 2025; 15:1537688.

PMID: 40046626 PMC: 11879819. DOI: 10.3389/fonc.2025.1537688.


The Role of Machine Learning Models in Predicting Cirrhosis Mortality: A Systematic Review.

Mohamud K, Elzubair Eltahir S, Ahmed Alhardalo H, Albashir H, Ali Mohamed Zain N, Abdelrahman Ibrahim M Cureus. 2025; 17(1):e78155.

PMID: 40026938 PMC: 11867977. DOI: 10.7759/cureus.78155.


Update on the Complications and Management of Liver Cirrhosis.

Fadlallah H, El Masri D, Bahmad H, Abou-Kheir W, El Masri J Med Sci (Basel). 2025; 13(1).

PMID: 39982238 PMC: 11843904. DOI: 10.3390/medsci13010013.


Development and external validation of Global Leadership Initiative on Malnutrition-dictated nomograms predicting long-term mortality in hospitalized patients with cirrhosis.

Liu Q, He Y, Yang F, Guo G, Yang W, Wu L Sci Prog. 2025; 108(1):368504251320157.

PMID: 39967253 PMC: 11837080. DOI: 10.1177/00368504251320157.


Disease trajectory and competing risks of patients with cirrhosis in the US.

Mohammadi M, Hasjim B, Balbale S, Polineni P, Huang A, Paukner M PLoS One. 2025; 20(2):e0313152.

PMID: 39951428 PMC: 11828360. DOI: 10.1371/journal.pone.0313152.


References
1.
Cerqueira R, Andrade L, Correia M, Fernandes C, Manso M . Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol. 2012; 24(5):551-7. DOI: 10.1097/MEG.0b013e3283510448. View

2.
Zapata R, Innocenti F, Sanhueza E, Humeres R, Rios H, Suarez L . Predictive models in cirrhosis: correlation with the final results and costs of liver transplantation in Chile. Transplant Proc. 2004; 36(6):1671-2. DOI: 10.1016/j.transproceed.2004.06.071. View

3.
Attia K, Ackoundou-NGuessan K, Ndri-Yoman A, Mahassadi A, Messou E, Bathaix Y . Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol. 2008; 14(2):286-91. PMC: 2675128. DOI: 10.3748/wjg.14.286. View

4.
Fejfar T, Safka V, Hulek P, Vanasek T, Krajina A, Jirkovsky V . [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS]. Vnitr Lek. 2006; 52(9):771-6. View

5.
Costa B, Castro Sousa F, Serodio M, Carvalho C . Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases. World J Surg. 2009; 33(8):1711-9. DOI: 10.1007/s00268-009-0093-4. View